Skip to main content
Equibles

BARCLAYS PLC

Position in PGEN — Precigen, Inc.

CIK 312069 LONDON, X0
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,308,796
+$3,405,934 QoQ
Shares Held
931,368
+89.4% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 210 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. PGEN ranks #38 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in PGEN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,308,796 931,368
2026-03-31 $1,902,862 491,696
2025-12-31 $3,617,280 865,378
2025-09-30 $1,828,765 555,856
2025-06-30 $435,113 306,418
2025-03-31 $267,953 179,835
2024-12-31 $272,046 242,899
2024-09-30 $179,884 189,353
2024-06-30 $103,033 65,212
2024-03-31 $164,278 113,296
2023-12-31 $276,762 206,540
2023-09-30 $64,030 45,092
2023-06-30 $56,183 48,856
2023-03-31 $88,500 83,491
2022-12-31 $74,490 49,007
2022-09-30 $55,509 26,184
2022-06-30 $6,793 5,070
2022-03-31 $10 5